Correlation Between Neurocrine Biosciences and Amneal Pharmaceuticals,
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Amneal Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Amneal Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Amneal Pharmaceuticals, Class, you can compare the effects of market volatilities on Neurocrine Biosciences and Amneal Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Amneal Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Amneal Pharmaceuticals,.
Diversification Opportunities for Neurocrine Biosciences and Amneal Pharmaceuticals,
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Neurocrine and Amneal is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Amneal Pharmaceuticals, Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amneal Pharmaceuticals, and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Amneal Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amneal Pharmaceuticals, has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Amneal Pharmaceuticals, go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and Amneal Pharmaceuticals,
Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 13.48 times less return on investment than Amneal Pharmaceuticals,. But when comparing it to its historical volatility, Neurocrine Biosciences is 1.93 times less risky than Amneal Pharmaceuticals,. It trades about 0.01 of its potential returns per unit of risk. Amneal Pharmaceuticals, Class is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 221.00 in Amneal Pharmaceuticals, Class on August 28, 2024 and sell it today you would earn a total of 617.00 from holding Amneal Pharmaceuticals, Class or generate 279.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neurocrine Biosciences vs. Amneal Pharmaceuticals, Class
Performance |
| Timeline |
| Neurocrine Biosciences |
| Amneal Pharmaceuticals, |
Neurocrine Biosciences and Amneal Pharmaceuticals, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurocrine Biosciences and Amneal Pharmaceuticals,
The main advantage of trading using opposite Neurocrine Biosciences and Amneal Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Amneal Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amneal Pharmaceuticals, will offset losses from the drop in Amneal Pharmaceuticals,'s long position.| Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
| Amneal Pharmaceuticals, vs. Alkermes Plc | Amneal Pharmaceuticals, vs. Neurocrine Biosciences | Amneal Pharmaceuticals, vs. Intracellular Th | Amneal Pharmaceuticals, vs. Dynavax Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |